ORSOBIO

OrsoBio is a clinical-stage biopharmaceutical company developing first-in-class therapies to address the underlying causes of organ dysfunction in patients with severe metabolic disorders. Our dedicated, highly skilled, and cohesive team of physicians and scientists bring decades of clinical and drug development experience, from academia and industry, that serves as the foundation of our company... OrsoBio is developing novel therapies to treat patients with severe metabolic disorders, including obesity, diabetes, severe dyslipidemias, NASH, and more.

Also known as: OrsoBio, Inc.